PRRT2 and cholangiocarcinoma: Serum CA50 levels of iCCA patients varied, ranging from 0.5 to 125,000 U/mL with the median value of 197.3 U/mL, which is significantly higher than that of non-CCA controls (median = 4.6 U/mL) (Figure 1A, p < 0.001).